OMCL OMNICELL, INC.

Nasdaq Electronic Computers DE CIK: 0000926326
AI RATING
SELL
72% Confidence

Investment Thesis

OmniCell exhibits critical profitability deterioration with net margins of only 3.7%, ROE of 0.9%, and a severe 85.2% YoY EPS decline, indicating fundamental operational challenges despite a fortress balance sheet. While the company generates reasonable free cash flow and maintains zero debt, the inability to convert a 45.3% gross margin into adequate operating profits (5.4% margin) suggests structural cost control issues that severely constrain shareholder returns.

Strengths

  • + Zero long-term debt with $239.2M cash position provides financial flexibility
  • + Solid free cash flow generation of $42.1M (13.6% FCF margin) exceeds net income
  • + 45.3% gross margin demonstrates product pricing power and market demand

Risks

  • ! Dramatic 85.2% YoY EPS decline signals material deterioration in earnings power
  • ! Critically low returns: ROE of 0.9% and ROA of 0.6% indicate capital is not being deployed efficiently
  • ! Operating margin of only 5.4% despite 45.3% gross margin reveals serious operating expense management issues

Key Metrics to Watch

Financial Metrics

Revenue
309.9M
Net Income
11.4M
EPS (Diluted)
$0.25
Free Cash Flow
42.1M
Total Assets
2.0B
Cash
239.2M

Profitability Ratios

Gross Margin 45.3%
Operating Margin 5.4%
Net Margin 3.7%
ROE 0.9%
ROA 0.6%
FCF Margin 13.6%

Balance Sheet & Liquidity

Current Ratio
1.50x
Quick Ratio
1.29x
Debt/Equity
0.00x
Debt/Assets
37.3%
Interest Coverage
84.27x
Long-term Debt
0.0
Disclaimer: This analysis is generated by AI based on publicly available SEC EDGAR filings. It does not include stock price data and should not be considered financial advice. All fundamental data is sourced from SEC public domain filings. Always conduct your own research before making investment decisions.
Data Source: SEC EDGAR | Analysis Date: 2026-05-07T06:47:59.510097 | Data as of: 2026-03-31 | Powered by Claude AI